Pharma & Healthcare
Global Injection General Anesthetics Drug Market Research Report 2026
- Feb 24, 26
- ID: 721103
- Pages: 120
- Figures: 119
- Views: 2
This report delivers a comprehensive overview of the global Injection General Anesthetics Drug market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Injection General Anesthetics Drug. The Injection General Anesthetics Drug market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Injection General Anesthetics Drug market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Injection General Anesthetics Drug manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Aspen Pharma
Fresenius-Kabi
AbbVie
Baxter Healthcare
B.Braun
Maruishi
Piramal
Hikma Pharmaceuticals
Yichang Humanwell
Nhwa
Hengrui
Xi'an Libang
Pfizer
Segment by Type
Remifentanil
Propofol
Etomidate
Other
by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Injection General Anesthetics Drug manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Injection General Anesthetics Drug sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Injection General Anesthetics Drug market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Injection General Anesthetics Drug manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Aspen Pharma
Fresenius-Kabi
AbbVie
Baxter Healthcare
B.Braun
Maruishi
Piramal
Hikma Pharmaceuticals
Yichang Humanwell
Nhwa
Hengrui
Xi'an Libang
Pfizer
Segment by Type
Remifentanil
Propofol
Etomidate
Other
by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Injection General Anesthetics Drug manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Injection General Anesthetics Drug sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Injection General Anesthetics Drug Market Overview
1.1 Product Definition
1.2 Injection General Anesthetics Drug by Type
1.2.1 Global Injection General Anesthetics Drug Market Value by Type: 2025 vs 2032
1.2.2 Remifentanil
1.2.3 Propofol
1.2.4 Etomidate
1.2.5 Other
1.3 Injection General Anesthetics Drug by Application
1.3.1 Global Injection General Anesthetics Drug Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Injection General Anesthetics Drug Market Size Estimates and Forecasts
1.4.1 Global Injection General Anesthetics Drug Revenue 2021–2032
1.4.2 Global Injection General Anesthetics Drug Sales 2021–2032
1.4.3 Global Injection General Anesthetics Drug Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Injection General Anesthetics Drug Market Competition by Manufacturers
2.1 Global Injection General Anesthetics Drug Sales Market Share by Manufacturers (2021–2026)
2.2 Global Injection General Anesthetics Drug Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Injection General Anesthetics Drug Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Injection General Anesthetics Drug, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Injection General Anesthetics Drug, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Injection General Anesthetics Drug, Product Types and Applications
2.7 Global Key Manufacturers of Injection General Anesthetics Drug, Date of Entry into the Industry
2.8 Global Injection General Anesthetics Drug Market Competitive Situation and Trends
2.8.1 Global Injection General Anesthetics Drug Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Injection General Anesthetics Drug Players Market Share by Revenue
2.8.3 Global Injection General Anesthetics Drug Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Injection General Anesthetics Drug Market Scenario by Region
3.1 Global Injection General Anesthetics Drug Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Injection General Anesthetics Drug Sales by Region: 2021–2032
3.2.1 Global Injection General Anesthetics Drug Sales by Region: 2021–2026
3.2.2 Global Injection General Anesthetics Drug Sales by Region: 2027–2032
3.3 Global Injection General Anesthetics Drug Revenue by Region: 2021–2032
3.3.1 Global Injection General Anesthetics Drug Revenue by Region: 2021–2026
3.3.2 Global Injection General Anesthetics Drug Revenue by Region: 2027–2032
3.4 North America Injection General Anesthetics Drug Market Facts & Figures by Country
3.4.1 North America Injection General Anesthetics Drug Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Injection General Anesthetics Drug Sales by Country (2021–2032)
3.4.3 North America Injection General Anesthetics Drug Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Injection General Anesthetics Drug Market Facts & Figures by Country
3.5.1 Europe Injection General Anesthetics Drug Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Injection General Anesthetics Drug Sales by Country (2021–2032)
3.5.3 Europe Injection General Anesthetics Drug Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Injection General Anesthetics Drug Market Facts & Figures by Region
3.6.1 Asia Pacific Injection General Anesthetics Drug Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Injection General Anesthetics Drug Sales by Region (2021–2032)
3.6.3 Asia Pacific Injection General Anesthetics Drug Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Injection General Anesthetics Drug Market Facts & Figures by Country
3.7.1 Latin America Injection General Anesthetics Drug Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Injection General Anesthetics Drug Sales by Country (2021–2032)
3.7.3 Latin America Injection General Anesthetics Drug Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Injection General Anesthetics Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Injection General Anesthetics Drug Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Injection General Anesthetics Drug Sales by Country (2021–2032)
3.8.3 Middle East and Africa Injection General Anesthetics Drug Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Injection General Anesthetics Drug Sales by Type (2021–2032)
4.1.1 Global Injection General Anesthetics Drug Sales by Type (2021–2026)
4.1.2 Global Injection General Anesthetics Drug Sales by Type (2027–2032)
4.1.3 Global Injection General Anesthetics Drug Sales Market Share by Type (2021–2032)
4.2 Global Injection General Anesthetics Drug Revenue by Type (2021–2032)
4.2.1 Global Injection General Anesthetics Drug Revenue by Type (2021–2026)
4.2.2 Global Injection General Anesthetics Drug Revenue by Type (2027–2032)
4.2.3 Global Injection General Anesthetics Drug Revenue Market Share by Type (2021–2032)
4.3 Global Injection General Anesthetics Drug Price by Type (2021–2032)
5 Segment by Application
5.1 Global Injection General Anesthetics Drug Sales by Application (2021–2032)
5.1.1 Global Injection General Anesthetics Drug Sales by Application (2021–2026)
5.1.2 Global Injection General Anesthetics Drug Sales by Application (2027–2032)
5.1.3 Global Injection General Anesthetics Drug Sales Market Share by Application (2021–2032)
5.2 Global Injection General Anesthetics Drug Revenue by Application (2021–2032)
5.2.1 Global Injection General Anesthetics Drug Revenue by Application (2021–2026)
5.2.2 Global Injection General Anesthetics Drug Revenue by Application (2027–2032)
5.2.3 Global Injection General Anesthetics Drug Revenue Market Share by Application (2021–2032)
5.3 Global Injection General Anesthetics Drug Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Aspen Pharma
6.1.1 Aspen Pharma Company Information
6.1.2 Aspen Pharma Description and Business Overview
6.1.3 Aspen Pharma Injection General Anesthetics Drug Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Aspen Pharma Injection General Anesthetics Drug Product Portfolio
6.1.5 Aspen Pharma Recent Developments/Updates
6.2 Fresenius-Kabi
6.2.1 Fresenius-Kabi Company Information
6.2.2 Fresenius-Kabi Description and Business Overview
6.2.3 Fresenius-Kabi Injection General Anesthetics Drug Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Fresenius-Kabi Injection General Anesthetics Drug Product Portfolio
6.2.5 Fresenius-Kabi Recent Developments/Updates
6.3 AbbVie
6.3.1 AbbVie Company Information
6.3.2 AbbVie Description and Business Overview
6.3.3 AbbVie Injection General Anesthetics Drug Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 AbbVie Injection General Anesthetics Drug Product Portfolio
6.3.5 AbbVie Recent Developments/Updates
6.4 Baxter Healthcare
6.4.1 Baxter Healthcare Company Information
6.4.2 Baxter Healthcare Description and Business Overview
6.4.3 Baxter Healthcare Injection General Anesthetics Drug Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Baxter Healthcare Injection General Anesthetics Drug Product Portfolio
6.4.5 Baxter Healthcare Recent Developments/Updates
6.5 B.Braun
6.5.1 B.Braun Company Information
6.5.2 B.Braun Description and Business Overview
6.5.3 B.Braun Injection General Anesthetics Drug Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 B.Braun Injection General Anesthetics Drug Product Portfolio
6.5.5 B.Braun Recent Developments/Updates
6.6 Maruishi
6.6.1 Maruishi Company Information
6.6.2 Maruishi Description and Business Overview
6.6.3 Maruishi Injection General Anesthetics Drug Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Maruishi Injection General Anesthetics Drug Product Portfolio
6.6.5 Maruishi Recent Developments/Updates
6.7 Piramal
6.7.1 Piramal Company Information
6.7.2 Piramal Description and Business Overview
6.7.3 Piramal Injection General Anesthetics Drug Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Piramal Injection General Anesthetics Drug Product Portfolio
6.7.5 Piramal Recent Developments/Updates
6.8 Hikma Pharmaceuticals
6.8.1 Hikma Pharmaceuticals Company Information
6.8.2 Hikma Pharmaceuticals Description and Business Overview
6.8.3 Hikma Pharmaceuticals Injection General Anesthetics Drug Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Hikma Pharmaceuticals Injection General Anesthetics Drug Product Portfolio
6.8.5 Hikma Pharmaceuticals Recent Developments/Updates
6.9 Yichang Humanwell
6.9.1 Yichang Humanwell Company Information
6.9.2 Yichang Humanwell Description and Business Overview
6.9.3 Yichang Humanwell Injection General Anesthetics Drug Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Yichang Humanwell Injection General Anesthetics Drug Product Portfolio
6.9.5 Yichang Humanwell Recent Developments/Updates
6.10 Nhwa
6.10.1 Nhwa Company Information
6.10.2 Nhwa Description and Business Overview
6.10.3 Nhwa Injection General Anesthetics Drug Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Nhwa Injection General Anesthetics Drug Product Portfolio
6.10.5 Nhwa Recent Developments/Updates
6.11 Hengrui
6.11.1 Hengrui Company Information
6.11.2 Hengrui Description and Business Overview
6.11.3 Hengrui Injection General Anesthetics Drug Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Hengrui Injection General Anesthetics Drug Product Portfolio
6.11.5 Hengrui Recent Developments/Updates
6.12 Xi'an Libang
6.12.1 Xi'an Libang Company Information
6.12.2 Xi'an Libang Description and Business Overview
6.12.3 Xi'an Libang Injection General Anesthetics Drug Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Xi'an Libang Injection General Anesthetics Drug Product Portfolio
6.12.5 Xi'an Libang Recent Developments/Updates
6.13 Pfizer
6.13.1 Pfizer Company Information
6.13.2 Pfizer Description and Business Overview
6.13.3 Pfizer Injection General Anesthetics Drug Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Pfizer Injection General Anesthetics Drug Product Portfolio
6.13.5 Pfizer Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Injection General Anesthetics Drug Industry Chain Analysis
7.2 Injection General Anesthetics Drug Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Injection General Anesthetics Drug Production Mode & Process Analysis
7.4 Injection General Anesthetics Drug Sales and Marketing
7.4.1 Injection General Anesthetics Drug Sales Channels
7.4.2 Injection General Anesthetics Drug Distributors
7.5 Injection General Anesthetics Drug Customer Analysis
8 Injection General Anesthetics Drug Market Dynamics
8.1 Injection General Anesthetics Drug Industry Trends
8.2 Injection General Anesthetics Drug Market Drivers
8.3 Injection General Anesthetics Drug Market Challenges
8.4 Injection General Anesthetics Drug Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Injection General Anesthetics Drug by Type
1.2.1 Global Injection General Anesthetics Drug Market Value by Type: 2025 vs 2032
1.2.2 Remifentanil
1.2.3 Propofol
1.2.4 Etomidate
1.2.5 Other
1.3 Injection General Anesthetics Drug by Application
1.3.1 Global Injection General Anesthetics Drug Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Injection General Anesthetics Drug Market Size Estimates and Forecasts
1.4.1 Global Injection General Anesthetics Drug Revenue 2021–2032
1.4.2 Global Injection General Anesthetics Drug Sales 2021–2032
1.4.3 Global Injection General Anesthetics Drug Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Injection General Anesthetics Drug Market Competition by Manufacturers
2.1 Global Injection General Anesthetics Drug Sales Market Share by Manufacturers (2021–2026)
2.2 Global Injection General Anesthetics Drug Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Injection General Anesthetics Drug Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Injection General Anesthetics Drug, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Injection General Anesthetics Drug, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Injection General Anesthetics Drug, Product Types and Applications
2.7 Global Key Manufacturers of Injection General Anesthetics Drug, Date of Entry into the Industry
2.8 Global Injection General Anesthetics Drug Market Competitive Situation and Trends
2.8.1 Global Injection General Anesthetics Drug Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Injection General Anesthetics Drug Players Market Share by Revenue
2.8.3 Global Injection General Anesthetics Drug Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Injection General Anesthetics Drug Market Scenario by Region
3.1 Global Injection General Anesthetics Drug Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Injection General Anesthetics Drug Sales by Region: 2021–2032
3.2.1 Global Injection General Anesthetics Drug Sales by Region: 2021–2026
3.2.2 Global Injection General Anesthetics Drug Sales by Region: 2027–2032
3.3 Global Injection General Anesthetics Drug Revenue by Region: 2021–2032
3.3.1 Global Injection General Anesthetics Drug Revenue by Region: 2021–2026
3.3.2 Global Injection General Anesthetics Drug Revenue by Region: 2027–2032
3.4 North America Injection General Anesthetics Drug Market Facts & Figures by Country
3.4.1 North America Injection General Anesthetics Drug Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Injection General Anesthetics Drug Sales by Country (2021–2032)
3.4.3 North America Injection General Anesthetics Drug Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Injection General Anesthetics Drug Market Facts & Figures by Country
3.5.1 Europe Injection General Anesthetics Drug Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Injection General Anesthetics Drug Sales by Country (2021–2032)
3.5.3 Europe Injection General Anesthetics Drug Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Injection General Anesthetics Drug Market Facts & Figures by Region
3.6.1 Asia Pacific Injection General Anesthetics Drug Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Injection General Anesthetics Drug Sales by Region (2021–2032)
3.6.3 Asia Pacific Injection General Anesthetics Drug Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Injection General Anesthetics Drug Market Facts & Figures by Country
3.7.1 Latin America Injection General Anesthetics Drug Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Injection General Anesthetics Drug Sales by Country (2021–2032)
3.7.3 Latin America Injection General Anesthetics Drug Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Injection General Anesthetics Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Injection General Anesthetics Drug Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Injection General Anesthetics Drug Sales by Country (2021–2032)
3.8.3 Middle East and Africa Injection General Anesthetics Drug Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Injection General Anesthetics Drug Sales by Type (2021–2032)
4.1.1 Global Injection General Anesthetics Drug Sales by Type (2021–2026)
4.1.2 Global Injection General Anesthetics Drug Sales by Type (2027–2032)
4.1.3 Global Injection General Anesthetics Drug Sales Market Share by Type (2021–2032)
4.2 Global Injection General Anesthetics Drug Revenue by Type (2021–2032)
4.2.1 Global Injection General Anesthetics Drug Revenue by Type (2021–2026)
4.2.2 Global Injection General Anesthetics Drug Revenue by Type (2027–2032)
4.2.3 Global Injection General Anesthetics Drug Revenue Market Share by Type (2021–2032)
4.3 Global Injection General Anesthetics Drug Price by Type (2021–2032)
5 Segment by Application
5.1 Global Injection General Anesthetics Drug Sales by Application (2021–2032)
5.1.1 Global Injection General Anesthetics Drug Sales by Application (2021–2026)
5.1.2 Global Injection General Anesthetics Drug Sales by Application (2027–2032)
5.1.3 Global Injection General Anesthetics Drug Sales Market Share by Application (2021–2032)
5.2 Global Injection General Anesthetics Drug Revenue by Application (2021–2032)
5.2.1 Global Injection General Anesthetics Drug Revenue by Application (2021–2026)
5.2.2 Global Injection General Anesthetics Drug Revenue by Application (2027–2032)
5.2.3 Global Injection General Anesthetics Drug Revenue Market Share by Application (2021–2032)
5.3 Global Injection General Anesthetics Drug Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Aspen Pharma
6.1.1 Aspen Pharma Company Information
6.1.2 Aspen Pharma Description and Business Overview
6.1.3 Aspen Pharma Injection General Anesthetics Drug Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Aspen Pharma Injection General Anesthetics Drug Product Portfolio
6.1.5 Aspen Pharma Recent Developments/Updates
6.2 Fresenius-Kabi
6.2.1 Fresenius-Kabi Company Information
6.2.2 Fresenius-Kabi Description and Business Overview
6.2.3 Fresenius-Kabi Injection General Anesthetics Drug Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Fresenius-Kabi Injection General Anesthetics Drug Product Portfolio
6.2.5 Fresenius-Kabi Recent Developments/Updates
6.3 AbbVie
6.3.1 AbbVie Company Information
6.3.2 AbbVie Description and Business Overview
6.3.3 AbbVie Injection General Anesthetics Drug Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 AbbVie Injection General Anesthetics Drug Product Portfolio
6.3.5 AbbVie Recent Developments/Updates
6.4 Baxter Healthcare
6.4.1 Baxter Healthcare Company Information
6.4.2 Baxter Healthcare Description and Business Overview
6.4.3 Baxter Healthcare Injection General Anesthetics Drug Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Baxter Healthcare Injection General Anesthetics Drug Product Portfolio
6.4.5 Baxter Healthcare Recent Developments/Updates
6.5 B.Braun
6.5.1 B.Braun Company Information
6.5.2 B.Braun Description and Business Overview
6.5.3 B.Braun Injection General Anesthetics Drug Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 B.Braun Injection General Anesthetics Drug Product Portfolio
6.5.5 B.Braun Recent Developments/Updates
6.6 Maruishi
6.6.1 Maruishi Company Information
6.6.2 Maruishi Description and Business Overview
6.6.3 Maruishi Injection General Anesthetics Drug Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Maruishi Injection General Anesthetics Drug Product Portfolio
6.6.5 Maruishi Recent Developments/Updates
6.7 Piramal
6.7.1 Piramal Company Information
6.7.2 Piramal Description and Business Overview
6.7.3 Piramal Injection General Anesthetics Drug Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Piramal Injection General Anesthetics Drug Product Portfolio
6.7.5 Piramal Recent Developments/Updates
6.8 Hikma Pharmaceuticals
6.8.1 Hikma Pharmaceuticals Company Information
6.8.2 Hikma Pharmaceuticals Description and Business Overview
6.8.3 Hikma Pharmaceuticals Injection General Anesthetics Drug Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Hikma Pharmaceuticals Injection General Anesthetics Drug Product Portfolio
6.8.5 Hikma Pharmaceuticals Recent Developments/Updates
6.9 Yichang Humanwell
6.9.1 Yichang Humanwell Company Information
6.9.2 Yichang Humanwell Description and Business Overview
6.9.3 Yichang Humanwell Injection General Anesthetics Drug Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Yichang Humanwell Injection General Anesthetics Drug Product Portfolio
6.9.5 Yichang Humanwell Recent Developments/Updates
6.10 Nhwa
6.10.1 Nhwa Company Information
6.10.2 Nhwa Description and Business Overview
6.10.3 Nhwa Injection General Anesthetics Drug Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Nhwa Injection General Anesthetics Drug Product Portfolio
6.10.5 Nhwa Recent Developments/Updates
6.11 Hengrui
6.11.1 Hengrui Company Information
6.11.2 Hengrui Description and Business Overview
6.11.3 Hengrui Injection General Anesthetics Drug Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Hengrui Injection General Anesthetics Drug Product Portfolio
6.11.5 Hengrui Recent Developments/Updates
6.12 Xi'an Libang
6.12.1 Xi'an Libang Company Information
6.12.2 Xi'an Libang Description and Business Overview
6.12.3 Xi'an Libang Injection General Anesthetics Drug Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Xi'an Libang Injection General Anesthetics Drug Product Portfolio
6.12.5 Xi'an Libang Recent Developments/Updates
6.13 Pfizer
6.13.1 Pfizer Company Information
6.13.2 Pfizer Description and Business Overview
6.13.3 Pfizer Injection General Anesthetics Drug Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Pfizer Injection General Anesthetics Drug Product Portfolio
6.13.5 Pfizer Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Injection General Anesthetics Drug Industry Chain Analysis
7.2 Injection General Anesthetics Drug Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Injection General Anesthetics Drug Production Mode & Process Analysis
7.4 Injection General Anesthetics Drug Sales and Marketing
7.4.1 Injection General Anesthetics Drug Sales Channels
7.4.2 Injection General Anesthetics Drug Distributors
7.5 Injection General Anesthetics Drug Customer Analysis
8 Injection General Anesthetics Drug Market Dynamics
8.1 Injection General Anesthetics Drug Industry Trends
8.2 Injection General Anesthetics Drug Market Drivers
8.3 Injection General Anesthetics Drug Market Challenges
8.4 Injection General Anesthetics Drug Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Injection General Anesthetics Drug Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Injection General Anesthetics Drug Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Injection General Anesthetics Drug Market Competitive Situation by Manufacturers in 2025
Table 4. Global Injection General Anesthetics Drug Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Injection General Anesthetics Drug Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Injection General Anesthetics Drug Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Injection General Anesthetics Drug Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Injection General Anesthetics Drug Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Injection General Anesthetics Drug, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Injection General Anesthetics Drug, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Injection General Anesthetics Drug, Product Types and Applications
Table 12. Global Key Manufacturers of Injection General Anesthetics Drug, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Injection General Anesthetics Drug Companies by Tier (Tier 1, Tier 2, Tier 3), based on Injection General Anesthetics Drug Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Injection General Anesthetics Drug Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Injection General Anesthetics Drug Sales by Region (K Units), 2021–2026
Table 18. Global Injection General Anesthetics Drug Sales Market Share by Region (2021–2026)
Table 19. Global Injection General Anesthetics Drug Sales by Region (K Units), 2027–2032
Table 20. Global Injection General Anesthetics Drug Sales Market Share by Region (2027–2032)
Table 21. Global Injection General Anesthetics Drug Revenue by Region (US$ Million), 2021–2026
Table 22. Global Injection General Anesthetics Drug Revenue Market Share by Region (2021–2026)
Table 23. Global Injection General Anesthetics Drug Revenue by Region (US$ Million), 2027–2032
Table 24. Global Injection General Anesthetics Drug Revenue Market Share by Region (2027–2032)
Table 25. North America Injection General Anesthetics Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Injection General Anesthetics Drug Sales by Country (K Units), 2021–2026
Table 27. North America Injection General Anesthetics Drug Sales by Country (K Units), 2027–2032
Table 28. North America Injection General Anesthetics Drug Revenue by Country (US$ Million), 2021–2026
Table 29. North America Injection General Anesthetics Drug Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Injection General Anesthetics Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Injection General Anesthetics Drug Sales by Country (K Units), 2021–2026
Table 32. Europe Injection General Anesthetics Drug Sales by Country (K Units), 2027–2032
Table 33. Europe Injection General Anesthetics Drug Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Injection General Anesthetics Drug Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Injection General Anesthetics Drug Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Injection General Anesthetics Drug Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Injection General Anesthetics Drug Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Injection General Anesthetics Drug Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Injection General Anesthetics Drug Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Injection General Anesthetics Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Injection General Anesthetics Drug Sales by Country (K Units), 2021–2026
Table 42. Latin America Injection General Anesthetics Drug Sales by Country (K Units), 2027–2032
Table 43. Latin America Injection General Anesthetics Drug Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Injection General Anesthetics Drug Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Injection General Anesthetics Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Injection General Anesthetics Drug Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Injection General Anesthetics Drug Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Injection General Anesthetics Drug Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Injection General Anesthetics Drug Revenue by Country (US$ Million), 2027–2032
Table 50. Global Injection General Anesthetics Drug Sales (K Units) by Type (2021–2026)
Table 51. Global Injection General Anesthetics Drug Sales (K Units) by Type (2027–2032)
Table 52. Global Injection General Anesthetics Drug Sales Market Share by Type (2021–2026)
Table 53. Global Injection General Anesthetics Drug Sales Market Share by Type (2027–2032)
Table 54. Global Injection General Anesthetics Drug Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Injection General Anesthetics Drug Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Injection General Anesthetics Drug Revenue Market Share by Type (2021–2026)
Table 57. Global Injection General Anesthetics Drug Revenue Market Share by Type (2027–2032)
Table 58. Global Injection General Anesthetics Drug Price (US$/Unit) by Type (2021–2026)
Table 59. Global Injection General Anesthetics Drug Price (US$/Unit) by Type (2027–2032)
Table 60. Global Injection General Anesthetics Drug Sales (K Units) by Application (2021–2026)
Table 61. Global Injection General Anesthetics Drug Sales (K Units) by Application (2027–2032)
Table 62. Global Injection General Anesthetics Drug Sales Market Share by Application (2021–2026)
Table 63. Global Injection General Anesthetics Drug Sales Market Share by Application (2027–2032)
Table 64. Global Injection General Anesthetics Drug Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Injection General Anesthetics Drug Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Injection General Anesthetics Drug Revenue Market Share by Application (2021–2026)
Table 67. Global Injection General Anesthetics Drug Revenue Market Share by Application (2027–2032)
Table 68. Global Injection General Anesthetics Drug Price (US$/Unit) by Application (2021–2026)
Table 69. Global Injection General Anesthetics Drug Price (US$/Unit) by Application (2027–2032)
Table 70. Aspen Pharma Company Information
Table 71. Aspen Pharma Description and Business Overview
Table 72. Aspen Pharma Injection General Anesthetics Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Aspen Pharma Injection General Anesthetics Drug Product
Table 74. Aspen Pharma Recent Developments/Updates
Table 75. Fresenius-Kabi Company Information
Table 76. Fresenius-Kabi Description and Business Overview
Table 77. Fresenius-Kabi Injection General Anesthetics Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Fresenius-Kabi Injection General Anesthetics Drug Product
Table 79. Fresenius-Kabi Recent Developments/Updates
Table 80. AbbVie Company Information
Table 81. AbbVie Description and Business Overview
Table 82. AbbVie Injection General Anesthetics Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. AbbVie Injection General Anesthetics Drug Product
Table 84. AbbVie Recent Developments/Updates
Table 85. Baxter Healthcare Company Information
Table 86. Baxter Healthcare Description and Business Overview
Table 87. Baxter Healthcare Injection General Anesthetics Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Baxter Healthcare Injection General Anesthetics Drug Product
Table 89. Baxter Healthcare Recent Developments/Updates
Table 90. B.Braun Company Information
Table 91. B.Braun Description and Business Overview
Table 92. B.Braun Injection General Anesthetics Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. B.Braun Injection General Anesthetics Drug Product
Table 94. B.Braun Recent Developments/Updates
Table 95. Maruishi Company Information
Table 96. Maruishi Description and Business Overview
Table 97. Maruishi Injection General Anesthetics Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Maruishi Injection General Anesthetics Drug Product
Table 99. Maruishi Recent Developments/Updates
Table 100. Piramal Company Information
Table 101. Piramal Description and Business Overview
Table 102. Piramal Injection General Anesthetics Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Piramal Injection General Anesthetics Drug Product
Table 104. Piramal Recent Developments/Updates
Table 105. Hikma Pharmaceuticals Company Information
Table 106. Hikma Pharmaceuticals Description and Business Overview
Table 107. Hikma Pharmaceuticals Injection General Anesthetics Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Hikma Pharmaceuticals Injection General Anesthetics Drug Product
Table 109. Hikma Pharmaceuticals Recent Developments/Updates
Table 110. Yichang Humanwell Company Information
Table 111. Yichang Humanwell Description and Business Overview
Table 112. Yichang Humanwell Injection General Anesthetics Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Yichang Humanwell Injection General Anesthetics Drug Product
Table 114. Yichang Humanwell Recent Developments/Updates
Table 115. Nhwa Company Information
Table 116. Nhwa Description and Business Overview
Table 117. Nhwa Injection General Anesthetics Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Nhwa Injection General Anesthetics Drug Product
Table 119. Nhwa Recent Developments/Updates
Table 120. Hengrui Company Information
Table 121. Hengrui Description and Business Overview
Table 122. Hengrui Injection General Anesthetics Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Hengrui Injection General Anesthetics Drug Product
Table 124. Hengrui Recent Developments/Updates
Table 125. Xi'an Libang Company Information
Table 126. Xi'an Libang Description and Business Overview
Table 127. Xi'an Libang Injection General Anesthetics Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Xi'an Libang Injection General Anesthetics Drug Product
Table 129. Xi'an Libang Recent Developments/Updates
Table 130. Pfizer Company Information
Table 131. Pfizer Description and Business Overview
Table 132. Pfizer Injection General Anesthetics Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Pfizer Injection General Anesthetics Drug Product
Table 134. Pfizer Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Injection General Anesthetics Drug Distributors List
Table 138. Injection General Anesthetics Drug Customers List
Table 139. Injection General Anesthetics Drug Market Trends
Table 140. Injection General Anesthetics Drug Market Drivers
Table 141. Injection General Anesthetics Drug Market Challenges
Table 142. Injection General Anesthetics Drug Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Injection General Anesthetics Drug
Figure 2. Global Injection General Anesthetics Drug Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Injection General Anesthetics Drug Market Share by Type: 2025 & 2032
Figure 4. Remifentanil Product Picture
Figure 5. Propofol Product Picture
Figure 6. Etomidate Product Picture
Figure 7. Other Product Picture
Figure 8. Global Injection General Anesthetics Drug Market Value by Application (US$ Million), 2021–2032
Figure 9. Global Injection General Anesthetics Drug Market Share by Application: 2025 & 2032
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Other
Figure 13. Global Injection General Anesthetics Drug Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Injection General Anesthetics Drug Market Size (US$ Million), 2021–2032
Figure 15. Global Injection General Anesthetics Drug Sales (K Units), 2021–2032
Figure 16. Global Injection General Anesthetics Drug Average Price (US$/Unit), 2021–2032
Figure 17. Injection General Anesthetics Drug Report Years Considered
Figure 18. Injection General Anesthetics Drug Sales Share by Manufacturers in 2025
Figure 19. Global Injection General Anesthetics Drug Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global Injection General Anesthetics Drug Players: Market Share by Revenue in Injection General Anesthetics Drug in 2025
Figure 21. Injection General Anesthetics Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global Injection General Anesthetics Drug Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America Injection General Anesthetics Drug Sales Market Share by Country (2021–2032)
Figure 24. North America Injection General Anesthetics Drug Revenue Market Share by Country (2021–2032)
Figure 25. United States Injection General Anesthetics Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada Injection General Anesthetics Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe Injection General Anesthetics Drug Sales Market Share by Country (2021–2032)
Figure 28. Europe Injection General Anesthetics Drug Revenue Market Share by Country (2021–2032)
Figure 29. Germany Injection General Anesthetics Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France Injection General Anesthetics Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. Injection General Anesthetics Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy Injection General Anesthetics Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia Injection General Anesthetics Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific Injection General Anesthetics Drug Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific Injection General Anesthetics Drug Revenue Market Share by Region (2021–2032)
Figure 36. China Injection General Anesthetics Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan Injection General Anesthetics Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea Injection General Anesthetics Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India Injection General Anesthetics Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia Injection General Anesthetics Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan Injection General Anesthetics Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia Injection General Anesthetics Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America Injection General Anesthetics Drug Sales Market Share by Country (2021–2032)
Figure 44. Latin America Injection General Anesthetics Drug Revenue Market Share by Country (2021–2032)
Figure 45. Mexico Injection General Anesthetics Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil Injection General Anesthetics Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina Injection General Anesthetics Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia Injection General Anesthetics Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa Injection General Anesthetics Drug Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa Injection General Anesthetics Drug Revenue Market Share by Country (2021–2032)
Figure 51. Turkey Injection General Anesthetics Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia Injection General Anesthetics Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE Injection General Anesthetics Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of Injection General Anesthetics Drug by Type (2021–2032)
Figure 55. Global Revenue Market Share of Injection General Anesthetics Drug by Type (2021–2032)
Figure 56. Global Injection General Anesthetics Drug Price (US$/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of Injection General Anesthetics Drug by Application (2021–2032)
Figure 58. Global Revenue Market Share of Injection General Anesthetics Drug by Application (2021–2032)
Figure 59. Global Injection General Anesthetics Drug Price (US$/Unit) by Application (2021–2032)
Figure 60. Injection General Anesthetics Drug Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Injection General Anesthetics Drug Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Injection General Anesthetics Drug Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Injection General Anesthetics Drug Market Competitive Situation by Manufacturers in 2025
Table 4. Global Injection General Anesthetics Drug Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Injection General Anesthetics Drug Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Injection General Anesthetics Drug Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Injection General Anesthetics Drug Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Injection General Anesthetics Drug Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Injection General Anesthetics Drug, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Injection General Anesthetics Drug, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Injection General Anesthetics Drug, Product Types and Applications
Table 12. Global Key Manufacturers of Injection General Anesthetics Drug, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Injection General Anesthetics Drug Companies by Tier (Tier 1, Tier 2, Tier 3), based on Injection General Anesthetics Drug Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Injection General Anesthetics Drug Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Injection General Anesthetics Drug Sales by Region (K Units), 2021–2026
Table 18. Global Injection General Anesthetics Drug Sales Market Share by Region (2021–2026)
Table 19. Global Injection General Anesthetics Drug Sales by Region (K Units), 2027–2032
Table 20. Global Injection General Anesthetics Drug Sales Market Share by Region (2027–2032)
Table 21. Global Injection General Anesthetics Drug Revenue by Region (US$ Million), 2021–2026
Table 22. Global Injection General Anesthetics Drug Revenue Market Share by Region (2021–2026)
Table 23. Global Injection General Anesthetics Drug Revenue by Region (US$ Million), 2027–2032
Table 24. Global Injection General Anesthetics Drug Revenue Market Share by Region (2027–2032)
Table 25. North America Injection General Anesthetics Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Injection General Anesthetics Drug Sales by Country (K Units), 2021–2026
Table 27. North America Injection General Anesthetics Drug Sales by Country (K Units), 2027–2032
Table 28. North America Injection General Anesthetics Drug Revenue by Country (US$ Million), 2021–2026
Table 29. North America Injection General Anesthetics Drug Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Injection General Anesthetics Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Injection General Anesthetics Drug Sales by Country (K Units), 2021–2026
Table 32. Europe Injection General Anesthetics Drug Sales by Country (K Units), 2027–2032
Table 33. Europe Injection General Anesthetics Drug Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Injection General Anesthetics Drug Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Injection General Anesthetics Drug Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Injection General Anesthetics Drug Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Injection General Anesthetics Drug Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Injection General Anesthetics Drug Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Injection General Anesthetics Drug Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Injection General Anesthetics Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Injection General Anesthetics Drug Sales by Country (K Units), 2021–2026
Table 42. Latin America Injection General Anesthetics Drug Sales by Country (K Units), 2027–2032
Table 43. Latin America Injection General Anesthetics Drug Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Injection General Anesthetics Drug Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Injection General Anesthetics Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Injection General Anesthetics Drug Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Injection General Anesthetics Drug Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Injection General Anesthetics Drug Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Injection General Anesthetics Drug Revenue by Country (US$ Million), 2027–2032
Table 50. Global Injection General Anesthetics Drug Sales (K Units) by Type (2021–2026)
Table 51. Global Injection General Anesthetics Drug Sales (K Units) by Type (2027–2032)
Table 52. Global Injection General Anesthetics Drug Sales Market Share by Type (2021–2026)
Table 53. Global Injection General Anesthetics Drug Sales Market Share by Type (2027–2032)
Table 54. Global Injection General Anesthetics Drug Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Injection General Anesthetics Drug Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Injection General Anesthetics Drug Revenue Market Share by Type (2021–2026)
Table 57. Global Injection General Anesthetics Drug Revenue Market Share by Type (2027–2032)
Table 58. Global Injection General Anesthetics Drug Price (US$/Unit) by Type (2021–2026)
Table 59. Global Injection General Anesthetics Drug Price (US$/Unit) by Type (2027–2032)
Table 60. Global Injection General Anesthetics Drug Sales (K Units) by Application (2021–2026)
Table 61. Global Injection General Anesthetics Drug Sales (K Units) by Application (2027–2032)
Table 62. Global Injection General Anesthetics Drug Sales Market Share by Application (2021–2026)
Table 63. Global Injection General Anesthetics Drug Sales Market Share by Application (2027–2032)
Table 64. Global Injection General Anesthetics Drug Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Injection General Anesthetics Drug Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Injection General Anesthetics Drug Revenue Market Share by Application (2021–2026)
Table 67. Global Injection General Anesthetics Drug Revenue Market Share by Application (2027–2032)
Table 68. Global Injection General Anesthetics Drug Price (US$/Unit) by Application (2021–2026)
Table 69. Global Injection General Anesthetics Drug Price (US$/Unit) by Application (2027–2032)
Table 70. Aspen Pharma Company Information
Table 71. Aspen Pharma Description and Business Overview
Table 72. Aspen Pharma Injection General Anesthetics Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Aspen Pharma Injection General Anesthetics Drug Product
Table 74. Aspen Pharma Recent Developments/Updates
Table 75. Fresenius-Kabi Company Information
Table 76. Fresenius-Kabi Description and Business Overview
Table 77. Fresenius-Kabi Injection General Anesthetics Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Fresenius-Kabi Injection General Anesthetics Drug Product
Table 79. Fresenius-Kabi Recent Developments/Updates
Table 80. AbbVie Company Information
Table 81. AbbVie Description and Business Overview
Table 82. AbbVie Injection General Anesthetics Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. AbbVie Injection General Anesthetics Drug Product
Table 84. AbbVie Recent Developments/Updates
Table 85. Baxter Healthcare Company Information
Table 86. Baxter Healthcare Description and Business Overview
Table 87. Baxter Healthcare Injection General Anesthetics Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Baxter Healthcare Injection General Anesthetics Drug Product
Table 89. Baxter Healthcare Recent Developments/Updates
Table 90. B.Braun Company Information
Table 91. B.Braun Description and Business Overview
Table 92. B.Braun Injection General Anesthetics Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. B.Braun Injection General Anesthetics Drug Product
Table 94. B.Braun Recent Developments/Updates
Table 95. Maruishi Company Information
Table 96. Maruishi Description and Business Overview
Table 97. Maruishi Injection General Anesthetics Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Maruishi Injection General Anesthetics Drug Product
Table 99. Maruishi Recent Developments/Updates
Table 100. Piramal Company Information
Table 101. Piramal Description and Business Overview
Table 102. Piramal Injection General Anesthetics Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Piramal Injection General Anesthetics Drug Product
Table 104. Piramal Recent Developments/Updates
Table 105. Hikma Pharmaceuticals Company Information
Table 106. Hikma Pharmaceuticals Description and Business Overview
Table 107. Hikma Pharmaceuticals Injection General Anesthetics Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Hikma Pharmaceuticals Injection General Anesthetics Drug Product
Table 109. Hikma Pharmaceuticals Recent Developments/Updates
Table 110. Yichang Humanwell Company Information
Table 111. Yichang Humanwell Description and Business Overview
Table 112. Yichang Humanwell Injection General Anesthetics Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Yichang Humanwell Injection General Anesthetics Drug Product
Table 114. Yichang Humanwell Recent Developments/Updates
Table 115. Nhwa Company Information
Table 116. Nhwa Description and Business Overview
Table 117. Nhwa Injection General Anesthetics Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Nhwa Injection General Anesthetics Drug Product
Table 119. Nhwa Recent Developments/Updates
Table 120. Hengrui Company Information
Table 121. Hengrui Description and Business Overview
Table 122. Hengrui Injection General Anesthetics Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Hengrui Injection General Anesthetics Drug Product
Table 124. Hengrui Recent Developments/Updates
Table 125. Xi'an Libang Company Information
Table 126. Xi'an Libang Description and Business Overview
Table 127. Xi'an Libang Injection General Anesthetics Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Xi'an Libang Injection General Anesthetics Drug Product
Table 129. Xi'an Libang Recent Developments/Updates
Table 130. Pfizer Company Information
Table 131. Pfizer Description and Business Overview
Table 132. Pfizer Injection General Anesthetics Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Pfizer Injection General Anesthetics Drug Product
Table 134. Pfizer Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Injection General Anesthetics Drug Distributors List
Table 138. Injection General Anesthetics Drug Customers List
Table 139. Injection General Anesthetics Drug Market Trends
Table 140. Injection General Anesthetics Drug Market Drivers
Table 141. Injection General Anesthetics Drug Market Challenges
Table 142. Injection General Anesthetics Drug Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Injection General Anesthetics Drug
Figure 2. Global Injection General Anesthetics Drug Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Injection General Anesthetics Drug Market Share by Type: 2025 & 2032
Figure 4. Remifentanil Product Picture
Figure 5. Propofol Product Picture
Figure 6. Etomidate Product Picture
Figure 7. Other Product Picture
Figure 8. Global Injection General Anesthetics Drug Market Value by Application (US$ Million), 2021–2032
Figure 9. Global Injection General Anesthetics Drug Market Share by Application: 2025 & 2032
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Other
Figure 13. Global Injection General Anesthetics Drug Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Injection General Anesthetics Drug Market Size (US$ Million), 2021–2032
Figure 15. Global Injection General Anesthetics Drug Sales (K Units), 2021–2032
Figure 16. Global Injection General Anesthetics Drug Average Price (US$/Unit), 2021–2032
Figure 17. Injection General Anesthetics Drug Report Years Considered
Figure 18. Injection General Anesthetics Drug Sales Share by Manufacturers in 2025
Figure 19. Global Injection General Anesthetics Drug Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global Injection General Anesthetics Drug Players: Market Share by Revenue in Injection General Anesthetics Drug in 2025
Figure 21. Injection General Anesthetics Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global Injection General Anesthetics Drug Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America Injection General Anesthetics Drug Sales Market Share by Country (2021–2032)
Figure 24. North America Injection General Anesthetics Drug Revenue Market Share by Country (2021–2032)
Figure 25. United States Injection General Anesthetics Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada Injection General Anesthetics Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe Injection General Anesthetics Drug Sales Market Share by Country (2021–2032)
Figure 28. Europe Injection General Anesthetics Drug Revenue Market Share by Country (2021–2032)
Figure 29. Germany Injection General Anesthetics Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France Injection General Anesthetics Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. Injection General Anesthetics Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy Injection General Anesthetics Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia Injection General Anesthetics Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific Injection General Anesthetics Drug Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific Injection General Anesthetics Drug Revenue Market Share by Region (2021–2032)
Figure 36. China Injection General Anesthetics Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan Injection General Anesthetics Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea Injection General Anesthetics Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India Injection General Anesthetics Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia Injection General Anesthetics Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan Injection General Anesthetics Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia Injection General Anesthetics Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America Injection General Anesthetics Drug Sales Market Share by Country (2021–2032)
Figure 44. Latin America Injection General Anesthetics Drug Revenue Market Share by Country (2021–2032)
Figure 45. Mexico Injection General Anesthetics Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil Injection General Anesthetics Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina Injection General Anesthetics Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia Injection General Anesthetics Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa Injection General Anesthetics Drug Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa Injection General Anesthetics Drug Revenue Market Share by Country (2021–2032)
Figure 51. Turkey Injection General Anesthetics Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia Injection General Anesthetics Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE Injection General Anesthetics Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of Injection General Anesthetics Drug by Type (2021–2032)
Figure 55. Global Revenue Market Share of Injection General Anesthetics Drug by Type (2021–2032)
Figure 56. Global Injection General Anesthetics Drug Price (US$/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of Injection General Anesthetics Drug by Application (2021–2032)
Figure 58. Global Revenue Market Share of Injection General Anesthetics Drug by Application (2021–2032)
Figure 59. Global Injection General Anesthetics Drug Price (US$/Unit) by Application (2021–2032)
Figure 60. Injection General Anesthetics Drug Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Trichosanthes Kirilowii Extract Market Research Report 2026
Feb 24, 26
Global Glass Lined Containers Market Research Report 2026
Feb 24, 26
Global Open End Wrenches Market Research Report 2026
Feb 24, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232